Are NAD+ (Nicotinamide adenine dinucleotide) injections safe to use with Adderall (amphetamine and dextroamphetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of NAD+ Injections with Adderall

NAD+ injections should be avoided when taking Adderall due to lack of safety data and potential risk for drug interactions affecting cardiovascular function.

Understanding the Medications

Adderall

  • Combination of amphetamine and dextroamphetamine
  • DEA Schedule II controlled substance with high potential for abuse 1
  • Stimulates release of norepinephrine affecting both α- and β-adrenergic receptor sites
  • α-Adrenergic stimulation causes vasoconstriction and increases total peripheral resistance
  • β-Adrenergic stimulation increases heart rate, stroke volume, and skeletal muscle blood flow 1

NAD+ (Nicotinamide Adenine Dinucleotide)

  • Essential pyridine nucleotide cofactor involved in:
    • Oxidative phosphorylation
    • ATP production
    • DNA repair
    • Calcium-dependent secondary messaging
    • Gene expression 2

Safety Concerns

Lack of Drug Interaction Data

  • No published studies or guidelines specifically address interactions between NAD+ injections and Adderall
  • The practice parameter for stimulant medications does not mention NAD+ as a safe combination therapy 3
  • Current clinical guidelines focus on established medication combinations with known safety profiles

Cardiovascular Risks

  • Adderall causes significant cardiovascular effects including:
    • Tachycardia
    • Increased blood pressure
    • Vasoconstriction 1
  • NAD+ supplementation has been shown to affect:
    • Maximum heart rate
    • Cardiovascular parameters 2
  • The combined cardiovascular effects of both substances are unknown and potentially dangerous

Reported Side Effects

Adderall Side Effects

  • Hyperactivity
  • Hyperthermia
  • Tachycardia
  • Tachypnea
  • Mydriasis
  • Tremors
  • Seizures 1

NAD+ Side Effects

  • Muscle pain
  • Nervous disorders
  • Fatigue
  • Sleep disturbance
  • Headaches 2

Clinical Decision Making

Risk Assessment

  1. High-risk combination: Both substances affect cardiovascular function through different mechanisms
  2. Unknown interaction profile: No established safety data for this specific combination
  3. Potential for additive adverse effects: Both can cause nervous system effects and fatigue

Alternative Approaches

If considering NAD+ supplementation while on Adderall:

  • Oral NAD+ precursors may be safer than injections, as they have been more extensively studied 4
  • Timing separation between medications may reduce potential interactions (though this is theoretical without evidence)
  • Monitoring of cardiovascular parameters would be essential if attempting this combination

Recommendations for Specific Populations

Patients with Pre-existing Conditions

  • Cardiovascular disease: Absolutely contraindicated due to additive cardiovascular risks
  • Seizure disorders: High risk due to potential lowering of seizure threshold with stimulants 3
  • Hypertension: Increased risk of hypertensive crisis

Medication Combinations to Avoid

  • MAO inhibitors: Absolutely contraindicated with Adderall - can cause severe hypertension and cerebrovascular accidents 3
  • Adding NAD+ injections to this already risky landscape introduces unnecessary uncertainty

Conclusion

Given the lack of safety data and the potential for serious cardiovascular effects, NAD+ injections should be avoided in patients taking Adderall until proper clinical studies establish their safety profile together. The risk of unknown drug interactions outweighs the potential benefits of this combination.

References

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Research

Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.

American journal of physiology. Endocrinology and metabolism, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.

The journals of gerontology. Series A, Biological sciences and medical sciences, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.